Peimin Dai

Title: Peimin Dai: Innovator in Biotechnology

Introduction

Peimin Dai is a notable inventor based in Guangdong, China, recognized for his significant contributions to the field of biotechnology. With a total of two patents to his name, Dai has made remarkable strides in the development of pharmaceutical compositions.

Latest Patents

Dai's latest patents include groundbreaking work on recombinant human-basic fibroblast growth factor (rh-bFGF). The first patent focuses on a mutated nucleic acid molecule of rh-bFGF and a pharmaceutical composition comprising it, emphasizing its various uses. The second patent outlines a method for producing soluble rh-bFGF, along with the recombinant protein resulting from this method, and the mutated nucleic acid molecule encoding the rh-bFGF. These innovations highlight his impactful research in enhancing the efficacy of treatments in regenerative medicine.

Career Highlights

Peimin Dai currently works at Zhuhai Essex Bio-Pharmaceutical Co., Ltd., where he continues to push the boundaries of biomedical research. His work at the company aligns with the development of innovative therapies aimed at improving patient outcomes and advancing healthcare solutions.

Collaborations

Throughout his career, Dai has collaborated with notable colleagues such as Haizhou Fang and Bo Yang. Their partnership has been instrumental in the advancement of their shared goals in biotechnology, allowing them to combine their expertise to foster innovative solutions within the pharmaceutical sector.

Conclusion

Peimin Dai's dedication to his research and innovative spirit has positioned him as a key figure in the biotechnology landscape. His contributions through his patents reflect a commitment to enhancing medical therapies that could significantly impact patient care and treatment options in the future.